April 18th 2025
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Cost and lack of time keep women from seeing physicians
June 1st 2014Although women are often thought of as the drivers for healthcare in their families, many face financial and logistical barriers to obtaining healthcare for themselves, according to a new study by the Kaiser Family Foundation.
Read More
Black women at higher risk of triple-negative breast cancer
May 29th 2014A new analysis of data from a nationwide hospital-based dataset shows that black women have higher odds of being diagnosed with triple-negative breast cancer-a subtype associated with poorer prognosis-than do white women, regardless of socioeconomic status (SES). The report was published in the June issue of Breast Cancer Research and Treatment.
Read More
WHI report says physical activity may help prevent death due to ovarian cancer
May 8th 2014Women who engage in vigorous physical activity before a diagnosis of ovarian cancer may be at lower risk of dying of the disease, according to a new report by investigators from the Women’s Health Initiative (WHI).
Read More
FDA discouraging use of power morcellation
April 21st 2014A safety communication discouraging use of power morcellation during hysterectomy or myomectomy for fibroids has been issued by the Food and Drug Administration (FDA) because of concern about risk of inadvertent spread of unsuspected cancer to abdominal and pelvic cavities.
Read More
FDA panel recommends HPV DNA test as first-line cervical cancer screening
March 20th 2014In a unanimous vote, a Food and Drug Administration (FDA) advisory committee has recommended that the agency give premarket approval to a human papillomavirus (HPV) DNA test as first-line screening for cervical cancer.
Read More
Pelvic organ prolapse surgeries have similar outcomes
March 20th 2014According to a recent study in JAMA, neither the sacrospinous ligament fixation (SSLF) nor the uterosacral ligament vaginal vault suspension (ULS) procedure is superior to the other in the treatment of vaginal prolapse and stress urinary incontinence.
Read More
Oophorectomy cuts risk of cancer in BRCA1/2 carriers
March 6th 2014A study by Canadian researchers shows that preventive oophorectomy reduces risk of ovarian, fallopian tube, or peritoneal cancer by 80% in women who have BRCA1 or BRCA2 mutations. Published in The Journal of Clinical Oncology, the report also documented a 77% reduction in all-cause mortality.
Read More